Protective Effect of Probiotic Bacteria and Estrogen in Preventing HIV-1-Mediated Impairment of Epithelial Barrier Integrity in Female Genital Tract
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Approximately 40% of global HIV-1 transmission occurs in the female genital tract (FGT) through heterosexual transmission. Epithelial cells lining the FGT provide the first barrier to HIV-1 entry. Previous studies have suggested that certain hormonal contraceptives or a dysbiosis of the vaginal microbiota can enhance HIV-1 acquisition in the FGT. We examined the effects of lactobacilli and female sex hormones on the barrier functions and innate immune responses of primary endometrial genital epithelial cells (GECs). Two probiotic strains, Lactobacillus reuteri RC-14 and L. rhamnosus GR-1, were tested, as were sex hormones estrogen (E2), progesterone (P4), and the hormonal contraceptive medroxyprogesterone acetate (MPA). Our results demonstrate that probiotic lactobacilli enhance barrier function without affecting cytokines. Treatment of GECs with MPA resulted in reduced barrier function. In contrast, E2 treatment enhanced barrier function and reduced production of proinflammatory cytokines. Comparison of hormones plus lactobacilli as a pre-treatment prior to HIV exposure revealed a dominant effect of lactobacilli in preventing loss of barrier function by GECs. In summary, the combination of E2 and lactobacilli had the best protective effect against HIV-1 seen by enhancement of barrier function and reduction in proinflammatory cytokines. These studies provide insights into how probiotic lactobacilli in the female genital microenvironment can alter HIV-1-mediated barrier disruption and how the combination of E2 and lactobacilli may decrease susceptibility to primary HIV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Estrogen has been shown to decrease inflammation, increase epithelial barrier integrity and promote Lactobacillus growth factors that enhance protection against infection in in vitro studies [4, 40].”
From Feasibility, safety and tolerability of estrogen and/or probiotics for improving vaginal health in Canadian African, Caribbean, and Black women: A pilot phase 1 clinical trial (2025) · cites this paper as [40]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kimpton, J., & Emerman, M. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2232-2239.1992 · Cited by 908 · cited 1×
“Viral stocks were titered for infectious viral units per milliliter using the TZM-bl indicator cell assay as previously described [38].”
MethodVaginal Microbiome: Rethinking Health and Disease
Ma, B., Forney, L. J., & Ravel, J. (2012) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092611-150157 · Cited by 729 · cited 4×
“A Lactobacillus rich environment has been shown to exert protective effects against urogenital 274 diseases, including BV, yeast infection, HSV-2, and HIV-1 [33].”
InfluentialGosmann, C., Anahtar, M. N., Handley, S. A., Farcasanu, M., Abu-Ali, G., Bowman, B. A., Padavattan, N., Desai, C., Droit, L., Moodley, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2016.12.013 · Cited by 696 · cited 1×
“A decrease in Lactobacillus dominance and increased diversity is commonly associated with increased susceptibility to STIs including HIV-1, HSV-2, gonorrhea, and Chlamydia [31,32].”
BackgroundKarczewski, J., Troost, F. J., Konings, I., Dekker, J., Kleerebezem, M., Brummer, R.-J. M., & Wells, J. M. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00327.2009 · Cited by 676 · cited 1×
“In vitro studies using intestinal epithelial cells suggests that lactobacilli increase barrier function via tight-junction protein expression mediated by the TLR-2 pathway [53].”
BackgroundTargeting early infection to prevent HIV-1 mucosal transmission
Haase, A. T. (2010) · Nature · doi:10.1038/nature08757 · Cited by 593 · cited 1×
“In order for HIV-1 to establish successful infection, the virus must cross the epithelial barrier in order to access target cells [10].”
BackgroundNazli, A., Chan, O., Dobson-Belaire, W. N., Ouellet, M., Tremblay, M. J., Gray-Owen, S. D., Arsenault, A. L., & Kaushic, C. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000852 · Cited by 593 · cited 7×
“This production decreases GEC barrier integrity and subsequent microbial translocation of HIV-1 across the upper female genital tract epithelium [11,12].”
BackgroundMethodSelf-citationHunt, P. W., Sinclair, E., Rodriguez, B., Shive, C., Clagett, B., Funderburg, N., Robinson, J., Huang, Y., Epling, L., Martin, J. N., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu238 · Cited by 478
The role of sex hormones in immune protection of the female reproductive tract
Wira, C. R., Rodriguez-Garcia, M., & Patel, M. V. (2015) · Nature Reviews Immunology · doi:10.1038/nri3819 · Cited by 444 · cited 7×
“Furthermore, an increased susceptibility to sexually transmitted infections (STIs) including HIV-1 has been reported in women using the hormonal contraceptive DMPA [8,21,22,43].”
BackgroundInfluentialGenital Inflammation and the Risk of HIV Acquisition in Women
Masson, L., Passmore, J.-A. S., Liebenberg, L. J., Werner, L., Baxter, C., Arnold, K. B., Williamson, C., Little, F., Mansoor, L. E., Naranbhai, V., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ298 · Cited by 422 · cited 1×
“An inflammatory environment in the FGT is associated with a disruption in epithelial barrier function, which increases permeability between adjacent cells allowing microbial translocation of HIV-1 [11,44], and elevates production of proinflammatory TNF-α, causing further barrier damage [11].”
BackgroundLegrand, C., Bour, J. M., Jacob, C., Capiaumont, J., Martial, A., Marc, A., Wudtke, M., Kretzmer, G., Demangel, C., Duval, D., et al. (1992) · Journal of Biotechnology · doi:10.1016/0168-1656(92)90158-6 · Cited by 403
Cited by
Molina, N., Sola-Leyva, A., Saez-Lara, M., Plaza-Diaz, J., Tubić-Pavlović, A., Romero, B., Clavero, A., Mozas-Moreno, J., Fontes, J., & Altmäe, S. (2020) · Biomolecules · doi:10.3390/biom10040593 · Cited by 187
Roles of the Microbiota of the Female Reproductive Tract in Gynecological and Reproductive Health
Zhu, B., Tao, Z., Edupuganti, L., Serrano, M. G., & Buck, G. A. (2022) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00181-21 · Cited by 158
“attenuation of HIV infections by these taxa (22, 55).”
BackgroundDelgado-Diaz, D. J., Jesaveluk, B., Hayward, J. A., Tyssen, D. P., Alisoltani, A., Potgieter, M. G., Bell, L., Ross, E. J., Iranzadeh, A., Allali, I., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01337-5 · Cited by 146
“cultures in vitro has been demonstrated previously [31, 66].”
Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases
Kamel, M. S., Aleya, S., Alsubih, M., & Aleya, L. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14020217 · Cited by 114
“For instance, lactobacilli in the female genital tract produce lactic acid, inhibiting the growth of pathogenic yeasts and bacteria [42].”
BackgroundMicroorganisms in the reproductive system and probiotic's regulatory effects on reproductive health
Feng, T., & Liu, Y. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.03.017 · Cited by 93
“rhamnosus GR-1) treatment can strengthen the barrier function of endometrial epithelial cells destroyed by human immunodeficiency virus-1 [109].”
BackgroundThe Microbiome as a Key Regulator of Female Genital Tract Barrier Function
Plesniarski, A., Siddik, A. B., & Su, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.790627 · Cited by 67
“Co-culture of HIV-exposed GECs with the probiotic bacteria Lactobacillus reuteri RC-14 and Lactobacillus rhamnosus GR-1, as well as the female sex hormone estrogen, was shown to restore GEC barrier function and tight junction formation (Dizzell et al., 2019).”
BackgroundSchwecht, I., Nazli, A., Gill, B., & Kaushic, C. (2023) · Scientific Reports · doi:10.1038/s41598-023-47172-y · Cited by 54
“FITC-dextran (10 kDa; 2.4 mg/mL, Sigma-Aldrich) was added to the apical surface of VK2 cells after 24 h of metabolite treatment, as described elsewhere 30 .”
MethodInfluentialSelf-citationGut and Endometrial Microbiome Dysbiosis: A New Emergent Risk Factor for Endometrial Cancer
Boutriq, S., González-González, A., Plaza-Andrades, I. J., Laborda-Illanes, A., Sánchez‐Alcoholado, L., Peralta-Linero, J., Domínguez-Recio, M. E., Bermejo-Pérez, M. J., Lavado-Valenzuela, R., Alba, E., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070659 · Cited by 44
HIV Pathogenesis in the Human Female Reproductive Tract
Rodríguez‐García, M., Connors, K. A., & Ghosh, M. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-021-00546-1 · Cited by 46
Caerin 1 Antimicrobial Peptides that Inhibit HIV and Neisseria May Spare Protective Lactobacilli
Rollins‐Smith, L. A., Smith, P. B., Ledeczi, A. M., Rowe, J. M., & Reinert, L. K. (2020) · Antibiotics · doi:10.3390/antibiotics9100661 · Cited by 18
“Both of these species have been reported to have protective effects in the vaginal environment to prevent HIV transmission [12,13].”
BackgroundCheng, D., Li, N., Sun, Q., Wang, K., & Gao, F. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5644 · Cited by 19
“In vivo experiments and cervical‑epithelial models both demonstrate that lactate production by Lactobacillus spp. and the resulting acidic vaginal pH reinforce epithelial‑barrier integrity, thereby inhibiting colonization by anaerobes and pathogens (134,135).”
Microbiome–Maternal Tract Interactions in Women with Recurrent Implantation Failure
Kumar, M., Yan, Y., Jiang, L., Sze, C.-H., Kodithuwakku, S. P., Yeung, W. S. B., & Lee, C. (2025) · Microorganisms · doi:10.3390/microorganisms13040844 · Cited by 15
Hinton, A. O., Jr., Neikirk, K., Le, H., Harris, C., Oliver, A. F., Martin, P., & Gaye, A. (2024) · Aging advances. · doi:10.4103/agingadv.agingadv-d-24-00012 · Cited by 11
“Recent studies have indicated that HIV-1 transmission can be prevented in the female genital tract through a combination of elevated E2 levels and lactobacilli, 190 paralleling the results observed in pregnancy.”
Nanoparticle-Driven Modulation of Mucosal Immunity and Interplay with the Microbiome
Jung, W. H., & Son, Y. M. (2025) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2504.04033 · Cited by 11
“Beyond acid production, Lactobacillus limits pathogen adherence through competitive exclusion, forms a protective biofilm, and enhances mucosal barrier integrity by stimulating epithelial tight junctions and producing immune-modulating cytokines [89].”
Wei, X., Hong, L., Liang, H., Ren, K., Man, W., Zhao, Y., & Guo, P. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1556728 · Cited by 10
“Estrogen regulates innate immune and in fl ammatory responses in the female genital tract (FGT), playing a predominant role in reducing local in fl ammation, and exerting signi fi cant anti-in fl ammatory effects on epithelial cells, such as reducing the secretion of TNF-a , IL-1 a , and IL-8 (22, 23).”
Gut microbiota and chronic diseases: Role of probiotics
Bora, G., Gunna, A., Kumar, M. M., Morya, S., Awuchi, C. G., & Menaa, F. (2023) · Journal of Applied and Natural Science · doi:10.31018/jans.v15i2.4540 · Cited by 15
“A study conducted by Dizzell et al. (2019) showed Lactobacillus rhamnosus (GR-1) and Lactobacillus 0reuteri (RC-14) when given to HIV patients promoted the barrier function of epithelial cells of genital area.”
The role and challenges of regulating endometrial microbiome in uterine health and diseases
Yuan, C., Xie, K., Feng, L., Gao, S., & Cai, L. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2320247 · Cited by 9
“Oral and vaginal probiotics administration successfully improved the Lactobacillus content in patients with recurrent implantation failure (Dizzell et al. 2019).”
Estrogen prevented gingival barrier injury from Porphyromonas gingivalis lipopolysaccharide
Huang, F., Su, Z., Zhou, F., Wu, Y., Li, J., & Ren, B. (2025) · Infection and Immunity · doi:10.1128/iai.00410-24 · Cited by 8
“Recent advances in understanding the functions of E2 in HIV infection, inflammatory bowel disease, and eosinophilic esophagitis indicated that E2 contributed to the restoration of the epithelial barrier integrity damaged by different pathogens (19– 21).”
Current trends and future directions in probiotics research for HIV/AIDS
Cui, X., Xie, Z., Wu, Z. S., & LiQin, X. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1444552 · Cited by 7
“…GR-1 and Lactobacillus reuteri RC-14 (Liu et al., 2007; Anukam et al., 2008; Irvine et al., 2010; Hummelen et al., 2010; Hummelen et al., 2011a; Hemsworth et al., 2011; Dols et al., 2011; Hummelen et al., 2011b; Dizzell et al., 2019), using these two probiotics to intervene in women with AIDS.”
Rachman, B. E., Supranoto, Y. T. N., Iskandar, S. I., Asmarawati, T. P., Khairunisa, S. Q., Arfijanto, M. V., Hadi, U., Miftahussurur, M., Nasronudin, N., Kameoka, M., et al. (2025) · Viruses · doi:10.3390/v17121581 · Cited by 6
Patel, M. V., Rodríguez‐García, M., Shen, Z., & Wira, C. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-02681-6 · Cited by 6
Gill, B., Wessels, J. M., Hayes, C. L., Ratcliffe, J., Wokuri, J., Ball, E., Reid, G., Kaul, R., Rana, J., Alkhaifi, M., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0315576 · Cited by 5
Self-citationBeyond the Barrier: Epithelial Cells as Immune Sentinels in the Female Genital Tract
Jirik, L., Joshi, S., Nazli, A., & Kaushic, C. (2026) · American Journal of Reproductive Immunology · doi:10.1111/aji.70243 · Cited by 5
Self-citationBalle, C., Gupta, P. M., Tharp, G. K., Nelson, S. A., Konstantinus, I. N., Lennard, K. S., Jaumdally, S. Z., Happel, A., Barnabas, S. L., Gill, K., et al. (2022) · Frontiers in Reproductive Health · doi:10.3389/frph.2022.781687 · Cited by 3
Biocenosis of the vagina. Norm. Disruption. Restoration
Radzinskiy, V. E., Savicheva, A. M., Vorob'ev, S., Владимировна, С. Е., Shalepo, K. V., Budilovskaya, O. V., Husnutdinova, T., Krysanova, A. А., Guschin, A. E., Raevskaya, O., et al. (2023) · Publishing Center RIOR eBooks · doi:10.29039/978-5-907218-72-7 · Cited by 3
Innate Immune Protection Against HIV in the Female Genital Tract
Moldovan, G. E., Holmes, A., Pomicter, Z., & Rodríguez‐García, M. (2026) · American Journal of Reproductive Immunology · doi:10.1111/aji.70234 · Cited by 2
Discussion issues in the treatment of chronic endometritis
Дикке, Г. Б. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-086 · Cited by 2
Tarraf, A. A. (2021) · theses.fr (ABES) · doi:10.70675/545bd347z20bcz444cza534z622ac595baf9 · Cited by 3
Delgado-Diaz, D. J., Jesaveluk, B., Hayward, J. A., Tyssen, D. P., Alisoltani, A., Potgieter, M. G., Bell, L., Ross, E. J., Iranzadeh, A., Allali, I., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20762886
Metadata
- Authors
- Dizzell, S., Nazli, A., Reid, G., & Kaushic, C.
- Affiliations
- McMaster University (CA)
- Western University (CA)
- Corresponding author
- Kaushic, Charu
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-09-21
- Volume
- 8
- Issue
- 10
- Pages
- 1120
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC6829272
- OpenAlex
- W2973607368
- Cited by
- 30
- References
- 54
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 5 · 2020: 2
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Scholarship@Western (Western University) (submittedVersion, cc-by)
- Scholarship@Western (Western University) (submittedVersion)
- Funders
- Canadian Institutes of Health Research (FRN 126019, FRN 138657)
- Ontario HIV Treatment Network (AHRC 779)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- HIV-1, female reproductive tract, epithelial barrier integrity, probiotic lactobacilli, Lactobacillus reuteri RC-14, Lactobacillus rhamnosus GR-1, estrogen, medroxyprogesterone acetate, progesterone, hormonal contraception, inflammatory cytokines, vaginal microbiota, heterosexual transmission, innate immunity
- MeSH terms
- Adult, Antibiosis, Cell Membrane Permeability, Cells, Cultured, Epithelial Cells, Estradiol, Female, Genitalia, Female, Humans, Immunity, Innate, Lactobacillus, Middle Aged, Progesterone, HIV-1, HIV Infections, Cytoprotection, Probiotics, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.